Your browser doesn't support javascript.
loading
Acceptance, safety and immunogenicity of a booster dose of inactivated SARS-CoV-2 vaccine in adults with tuberculosis.
Zhan, Haoting; Yang, Li; Liu, Yongmei; Li, Haolong; Li, Xiaomeng; Wang, Haibin; Cao, Jinfeng; Kang, Shuhui; Guo, Xinru; Dai, Erhei; Li, Yongzhe.
Afiliação
  • Zhan H; Department of Clinical Laboratory, State key Laboratory of Complex, Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
  • Yang L; Department of Laboratory Medicine, the Fifth Hospital of Shijiazhuang, Hebei Medical University, Shijiazhuang, China.
  • Liu Y; Department of Clinical Laboratory, State key Laboratory of Complex, Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
  • Li H; Department of Clinical Laboratory, State key Laboratory of Complex, Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
  • Li X; Department of Clinical Laboratory, State key Laboratory of Complex, Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China; Department of Medical Research Center, Peking Union Medical College Hospital, Chin
  • Wang H; Department of Tuberculosis, the Fifth Hospital of Shijiazhuang, Shijiazhuang, China.
  • Cao J; Department of Tuberculosis, the Fifth Hospital of Shijiazhuang, Shijiazhuang, China.
  • Kang S; Department of Tuberculosis, the Fifth Hospital of Shijiazhuang, Shijiazhuang, China.
  • Guo X; Department of Laboratory Medicine, the Fifth Hospital of Shijiazhuang, Hebei Medical University, Shijiazhuang, China.
  • Dai E; Department of Laboratory Medicine, the Fifth Hospital of Shijiazhuang, Hebei Medical University, Shijiazhuang, China. Electronic address: daieh2008@126.com.
  • Li Y; Department of Clinical Laboratory, State key Laboratory of Complex, Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China. Electronic address: yongzhelipumch@126.com.
J Infect ; 86(5): e138-e141, 2023 05.
Article em En | MEDLINE | ID: mdl-36693568
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose / Vacinas contra COVID-19 / COVID-19 Limite: Adult / Humans Idioma: En Revista: J Infect Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose / Vacinas contra COVID-19 / COVID-19 Limite: Adult / Humans Idioma: En Revista: J Infect Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido